Duration of trastuzumab in HER2-positive metastatic breast cancer after complete remission: still debatable issue?

被引：0
|
作者：
Kadri Altundag
机构：
[1] MKA Breast Cancer Clinic,
来源：
Breast Cancer Research and Treatment | 2018年 / 167卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 815
相关论文
共 50 条
  • [21] TRASTUZUMAB EMTANSINE FOR THE TREATMENT OF HER2-POSITIVE METASTATIC BREAST CANCER
    Haddley, K.
    DRUGS OF TODAY, 2013, 49 (11) : 701 - 715
  • [22] Trastuzumab Deruxtecan in cerebral metastatic HER2-positive Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2025, 85 (04) : 354 - 354
  • [23] Trastuzumab beyond progression in HER2-positive metastatic breast cancer
    Al-Naqqash, Manwar
    Jasim Al-Serarati, Waleed
    Farooq Kareem, Tara
    BREAST JOURNAL, 2021, 27 (03): : 297 - 299
  • [24] When should trastuzumab be stopped after achieving complete response in HER2-positive metastatic breast cancer patients?
    Beda, Manuela
    Basso, Umberto
    Ghiotto, Cristina
    Monfardini, Silvio
    TUMORI JOURNAL, 2007, 93 (05): : 491 - 492
  • [25] Optimal Duration of Cardiac Monitoring in Metastatic HER2-positive Breast Cancer Patients Receiving Trastuzumab
    Chiu, K.
    Dubey, S.
    Bull, D.
    CLINICAL ONCOLOGY, 2014, 26 : S3 - S3
  • [26] Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
    Henry G. Kaplan
    Judith A. Malmgren
    Boya Guo
    Mary K. Atwood
    Breast Cancer Research and Treatment, 2022, 195 : 171 - 180
  • [27] Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure
    Antonarelli, G.
    Corti, C.
    Salimbeni, B. T.
    Tarantino, P.
    Zagami, P.
    Marra, A.
    Trapani, D.
    Tolaney, S.
    Cortes, J.
    Curigliano, G.
    ESMO OPEN, 2023, 8 (04)
  • [28] Is HER2-positive metastatic breast cancer still an incurable disease?
    Lambertini, Matteo
    Vaz-Luis, Ines
    LANCET ONCOLOGY, 2020, 21 (04): : 471 - 472
  • [29] Trastuzumab In HER2-Positive Metastatic Gastric Cancer
    Croxtall, Jamie D.
    McKeage, Kate
    DRUGS, 2010, 70 (17) : 2259 - 2267
  • [30] Trastuzumab Deruxtecan: A Review in Unresectable or Metastatic HER2-Positive Breast Cancer
    Nie, Tina
    Blair, Hannah A.
    TARGETED ONCOLOGY, 2023, 18 (03) : 463 - 470
12345